344 related articles for article (PubMed ID: 22360533)
1. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
2. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
5. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
[No Abstract] [Full Text] [Related]
7. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Structure and In Vitro Anti-Trypanosomal Activity of Non-Toxic Arylpyrrole-Based Chalcone Derivatives.
Zulu AI; Oderinlo OO; Kruger C; Isaacs M; Hoppe HC; Smith VJ; Veale CGL; Khanye SD
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260364
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
[TBL] [Abstract][Full Text] [Related]
11. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
[TBL] [Abstract][Full Text] [Related]
12. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity.
Spencer J; Rathnam RP; Harvey AL; Clements CJ; Clark RL; Barrett MP; Wong PE; Male L; Coles SJ; Mackay SP
Bioorg Med Chem; 2011 Mar; 19(5):1802-15. PubMed ID: 21306904
[TBL] [Abstract][Full Text] [Related]
14. Promising lead compounds for novel antiprotozoals.
Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Shibahara S; Kondo S; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Jul; 63(7):381-4. PubMed ID: 20661239
[No Abstract] [Full Text] [Related]
15. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
17. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
[TBL] [Abstract][Full Text] [Related]
18. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
20. In vitro antitrypanosomal activity of five low-MW antibiotics.
Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara-Tsukashima A; Takahashi Y; Onodera H; Yamada H; Omura S
J Antibiot (Tokyo); 2012 Feb; 65(2):113-4. PubMed ID: 22167160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
